Adverse effects on babies: diarrhoea · women in the postpartum period
It is very uncertain whether laxative changes adverse effects on babies: diarrhoea compared with placebo (very low certainty).
1 finding from 1 review
Incidence of postpartum constipation · women in the postpartum period
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · women in the postpartum period
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to first BM (№ women with 1st BM on day 1 after delivery) · women in the postpartum period
Laxative may leads to higher time to first bowel movement (BM) (№ women with 1st BM less than 24… compared with placebo (low certainty).
2 findings from 1 review
Time to first BM (№ women with 1st BM on day 2 after delivery) · women in the postpartum period
Laxative may leads to lower time to first BM (№ women with 1st BM on day 2 after delivery) compared with placebo (low certainty).
3 findings from 1 review
RR 0.23 [0.11, 0.45]
1 study · 471 participants
Low
RR 0.05 [0, 0.89]
1 study · 471 participants
Low
RR 0.22 [0.03, 1.87]
1 study · 471 participants
Very low
Adverse effects on women: abdominal cramps · women in the postpartum period
Laxative may leads to higher adverse effects on women: abdominal cramps compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · women with perineal pain in the early postpartum period
Aspirin may leads to higher adequate pain relief as reported by the woman (4 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review
Need for additional pain relief (4 to 8 hours) · women with perineal pain in the early postpartum period
It is very uncertain whether aspirin changes need for additional pain relief (4 to 8 hours) compared with placebo (very low certainty).
1 finding from 1 review
Maternal adverse events · women with perineal pain in the early postpartum period
It is very uncertain whether aspirin changes maternal adverse effects (4 to 8 hours) compared with placebo (very low certainty).
1 finding from 1 review
Neonatal drug adverse effects · women with perineal pain in the early postpartum period
1 finding from 1 review
Perineal pain at six weeks postpartum · women with perineal pain in the early postpartum period
1 finding from 1 review
Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes live birth compared with placebo (very low certainty).
1 finding from 1 review
Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pre‐eclampsia compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the mother ‐ Bleeding compared with placebo (very low certainty).
1 finding from 1 review
Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pregnancy loss compared with placebo (very low certainty).
1 finding from 1 review
Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes preterm delivery of a live infant compared with placebo (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes intrauterine growth restriction compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the child ‐ Congenital malformations compared with placebo (very low certainty).
1 finding from 1 review